Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
The Journal of Clinical Investigation|May 17, 2022
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancerShigeki Nanjo, Wei Wu, Niki Karachaliou, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinomaNeslihan Arife Kaya, David Tai, Xinru Lim, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Nature Communications|March 28, 2023
Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilitiesTeresa Lai Fong Ho, May Yin Lee, Hui Chin Goh, et al.
Nature Communications|January 12, 2021
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinomaPhuong H D Nguyen, Siming Ma, Cheryl Z J Phua, et al.
Science Advances|October 6, 2021
Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancerSer Yue Loo, Li Ping Toh, William Haowei Xie, et al.
Hepatology (Baltimore, Md.)|February 20, 2022
Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCCSheena Suthen, Chun Jye Lim, Phuong H D Nguyen, et al.
Pageof 21